Research interests
Biography
Craig Jamieson earned his BSc (Hons) in Chemistry at the University of Glasgow in 1996. His PhD studies were carried out under the direction of Professor R Ramage at the University of Edinburgh (1999). Following postdoctoral research under the supervision of Professor S V Ley at the University of Cambridge, in 2001 he was appointed as a Principal Scientist in GlaxoSmithKline's Discovery Medicinal Chemistry group working on a range of exploratory medicinal chemistry programmes. In 2004, Dr Jamieson joined Organon Laboratories (later Merck Research Labs) as a Group Leader in the Medicinal Chemistry Department, with responsibility for hit to clincal candidate optimisation. In August 2010 he was appointed as a John Anderson Research Lecturer in Chemical Biology, based in the Department of Pure and Applied Chemistry at the University of Strathclyde.
Research Interests
A major area of focus for our research continues to be in the Chemistry-Biology-Medicine continuum. In this regard, we have a number of active programmes centred around hit and lead identification on disease targets and mechanisms in areas of significant societal need, particularly in diseases of ageing. Allied to our work in the medicinal chemistry sphere, we also have a keen interest in the development of novel, enabling synthetic methodologies to enhance the armamentarium of molecule makers working in our arena. We collaborate with groups and industrial partners locally, nationally and globally in order to effectively meet our research goals.
Professional activities
- Gyros Protein Technologies
- Visiting researcher
- 1/6/2019
- Almac Sciences
- Visiting researcher
- 31/5/2019
- Aldeyra Therapeutics Inc
- Consultant
- 1/10/2018
- Arc Scientific
- Consultant
- 1/1/2016
- Syngenta Limited
- Visiting researcher
- 1/1/2014
- Journal of the American Chemical Society (Journal)
- Peer reviewer
- 1/1/2014
More professional activities
Projects
- Identifying New Drugs for the Treatment of Castrate Resistant Prostate Cancer
- Jamieson, Craig (Principal Investigator)
- 01-Jan-2020 - 31-Jan-2022
- Industrial Case Account - University of Strathclyde 2020 | Linden, Otto
- Burley, Glenn (Principal Investigator) Jamieson, Craig (Co-investigator) Linden, Otto (Research Co-investigator)
- 01-Jan-2020 - 01-Jan-2024
- Industrial Case Account - University of Strathclyde 2020 | Gibson, Mhairi
- Jamieson, Craig (Principal Investigator) Burley, Glenn (Co-investigator) Gibson, Mhairi (Research Co-investigator)
- 01-Jan-2020 - 01-Jan-2024
- Development and preclinical validation of novel PAR2 inhibitors for the treatment of Osteoarthritis
- McIntosh, Kathryn (Principal Investigator) Crilly, Anne (Co-investigator) Jamieson, Craig (Co-investigator) Plevin, Robin (Co-investigator) Rattray, Zahra (Co-investigator)
- 01-Jan-2020 - 30-Jan-2022
- The Androgen Receptor-amino terminal domain a Novel Druggable Target in the Treatment of Castrate
- Jamieson, Craig (Principal Investigator)
- 01-Jan-2019 - 31-Jan-2022
- Doctoral Training Partnership 2018-19 University of Strathclyde | Mowat, Jenna
- Jamieson, Craig (Principal Investigator) Burley, Glenn (Co-investigator) Mowat, Jenna (Research Co-investigator)
- 01-Jan-2019 - 01-Jan-2023
More projects
Address
Pure and Applied Chemistry
Thomas Graham Building
Thomas Graham Building
Location Map
View University of Strathclyde in a larger map